Cherishing the 100th Birth Anniversary of Sir James Wyte Black-Pioneer of the First Clinically Significant Beta-Blocker Dr Vilas P. Magarkar14 Jun 2024 11:15 AM ISTThe 100th birth anniversary of Sir James Wyte Black is a momentous occasion to reflect on his monumental contributions to medicine, particularly...
Harmonizing Adult Vaccination Guidelines in India: Need of the Hour (Prof) Dr Agam Vora6 Jun 2024 12:36 PM ISTA. Need for Adult ImmunizationVaccine-preventable diseases (VPDs) are among the various diseases that threaten India's healthcare system. From this...
Applicability of FDC of Linagliptin and Dapagliflozin in T2DM: EVERGREEN Case Report Summaries Dr Jeegar Dattani24 May 2024 11:00 AM ISTThe EVERGREEN webinar, designed to guide physicians regarding the care of people with diabetes, highlighted the clinical applicability of a...
Beta Blockers: A Five-Decade Legacy and Spotlight on Metoprolol Dr. Rajiv Karnik17 May 2024 11:00 AM ISTSince their introduction over five decades ago, beta-blockers have revolutionized the landscape of cardiovascular medicine. Initially developed to...
Breaking the Chain: The Crucial Role of Prediabetes Screening in Preventing Diabetes and Its Complications Dr. Kaushik Biswas15 May 2024 10:41 AM ISTPreventing Diabetes -A Stitch in Time Saves Nine:Diabetes prevention has become extremely critical, necessitating all healthcare stakeholders'...
Prediabetes Needs Proactive Management In India: Why? Dr Manoj Khandelwal18 April 2024 11:00 AM IST Prediabetes, also termed intermediate hyperglycemia or non-diabetic hyperglycemia, a high-risk state for developing diabetes, is defined by...
EVERGREEN Webinar: Clinical FAQs on T2DM Care, Addressed by Dr V Mohan Dr Jeegar Dattani6 March 2024 12:29 PM ISTThe Evergreen webinar addressed the clinical applicability of Linagliptin and Dapagliflozin in real-world clinical scenarios of type 2 diabetes....
2023 In Review: Major Developments In The Field Of Endocrinology Dr Akhil Krishna26 Dec 2023 11:15 AM IST Let us take a glimpse into the notable progress and accomplishments within the field of endocrinology for the year 2023. This overview showcases...
Top Ten Landmark Trials Across Cardiology - Dr Nihar Mehta Nihar Mehta20 Dec 2023 9:45 AM IST 1. Framingham Heart Study (1948): The inception of modern cardiovascular epidemiology, the Framingham Heart Study, laid the foundation for...
Linagliptin and Dapagliflozin: Therapeutic Applicability in T2DM with High CV Risk Dr. Kamal Kant Kohli13 Dec 2023 11:48 AM ISTType 2 Diabetes Mellitus and Cardiovascular DiseaseType 2 diabetes mellitus (T2DM) prevalence has been increasing globally, particularly in India (1)...
Linagliptin and Dapagliflozin: Evidence for Robust Glycemic Control and Reaping CV-CKD Benefits in T2DM (EVERGREEN) Practice Perspective Dr. Kamal Kant Kohli21 Nov 2023 12:14 PM ISTType 2 diabetes mellitus (T2DM) is growing alarmingly due to rapid urbanization, migration, aging population, and lifestyle changes; with Asia being...
Adverse Effects of Proton Pump Inhibitor Use in Patients with Cardiovascular Disease: Pharmacovigilance Attention Needed!! Dr. Kamal Kant Kohli8 Sept 2023 11:30 AM ISTSince the introduction of proton pump inhibitors (PPIs), they have steadily become the mainstay in treating acid-related disorders. The adoption of...
